TIMOTHY J. SCANNELL - Corporate Board Profile

INSULET CORP

Filing Date	Source Excerpt
2015-04-02	Mr. Scannell has served on our Board of Directors since August 2014. Since 2009, Mr. Scannell has served as group president of Medsurg & Neurotechnology at Stryker Corporation, a global leader in the medical technology industry. Mr. Scannell holds Bachelor of Science in business administration and Master of Business Administration from the University of Notre Dame.
2016-04-01	Mr. Scannell holds Bachelor of Science in Business Administration and a Master of Business Administration from the University of Notre Dame.
2017-04-07	Mr. Scannell brings extensive strategic, organizational, and operational skills and experience.
2018-04-06	Mr. Scannell holds a Bachelor of Science in Business Administration and an MBA, with extensive leadership experience at Stryker Corporation, but no software programming skills are mentioned.
2019-04-12	Mr. Scannell holds Bachelor of Science in Business Administration and Master of Business Administration degrees from the University of Notre Dame.
2020-04-13	Mr. Scannell brings extensive strategic, organizational, and operational skills and experience.
2021-04-13	Mr. Scannell holds Bachelor of Science in Business Administration and Master of Business Administration degrees from the University of Notre Dame. Mr. Scannell brings extensive strategic, organizational, and operational skills and experience.
2022-04-12	Mr. Scannell holds a Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame.
2023-04-06	Mr. Scannell has served on our Board of Directors since August 2014 and as our Board Chair since January 1, 2019. From October 1, 2021 to March 31, 2023, he served as an Executive Advisor at Stryker Corporation, one of the world's leading medical technology companies that offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. From August 2018 to September 2021, he served as the President and Chief Operating Officer at Stryker, and from 2009 to August 2018, he served as a Group President and oversaw Stryker’s MedSurg and Neurotechnology divisions. From 1990 to 2009, Mr. Scannell served in various roles at Stryker, including a range of sales and marketing leadership roles, Vice President and General Manager of its Biotech division and President of its Spine business. He also serves on the Board of Directors of Novocure, Renalytix plc and AeroClean Technologies. Mr. Scannell holds a Bachelor of Business Administration and an MBA from the University of Notre Dame. He brings extensive strategic, organizational, and operational skills and experience.
2024-04-09	Mr. Scannell has served on our Board of Directors since August 2014 and as our Board Chair since January 1, 2019. From October 2021 to March 2023, he served as an Executive Advisor at Stryker Corporation, one of the world’s leading medical technology companies that offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. From August 2018 to September 2021, he served as the President and Chief Operating Officer at Stryker, and from 2009 to August 2018, he served as a Group President and oversaw Stryker’s MedSurg and Neurotechnology divisions. From 1990 to 2009, Mr. Scannell served in various roles at Stryker, including a range of sales and marketing leadership roles, Vice President and General Manager of its Biotech division and President of its Spine business. Mr. Scannell holds a Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame. He brings extensive strategic, organizational, and operational skills and experience.